
Need to redefine GLP-1 therapy to adopt metabolism first path towards diabetes care: Expert
There is a need to redefine Glucagon-Like Peptide-1 (GLP-1) therapy to adopt metabolism first path towards diabetes care, says Hummsa Biotech founder Harshad Lalwani.“Biotechnology company,




